Genetic Technologies Ltd.
GENE
GENE was delisted on the 16th of October, 2024.
15 hedge funds and large institutions have $2.96M invested in Genetic Technologies Ltd. in 2016 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 3 closing their positions.
224% more capital invested
Capital invested by funds: $915K → $2.96M (+$2.05M)
133% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 3
50% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 2
36% more funds holding
Funds holding: 11 → 15 (+4)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$1.48M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.28M |
| 3 |
Renaissance Technologies
New York
|
+$267K |
| 4 |
TSS
Two Sigma Securities
New York
|
+$67.9K |
| 5 |
CG
Cutler Group
San Francisco,
California
|
+$5.96K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VKH
Virtu KCG Holdings
New York
|
-$24K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$19K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$2.25K |
| 4 |
PCM
Prelude Capital Management
New York
|
-$277 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SM
1
Sabby Management
Miami Beach,
Florida
| $1.16M | +$1.48M | +53,517 | New |
|
|
2
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $997K | +$1.28M | +46,168 | New |
|
|
3
Renaissance Technologies
New York
| $733K | +$267K | +9,620 | +40% |
|
|
TSS
4
Two Sigma Securities
New York
| $53K | +$67.9K | +2,450 | New |
|
|
AS
5
Arxis Securities
New York
| $12K | +$16.5K | +594 | New |
|
|
CG
6
Cutler Group
San Francisco,
California
| $5K | +$5.96K | +215 | +860% |
|
|
LTFS
7
Ladenburg Thalmann Financial Services
Miami,
Florida
| $3K | – | – | – |
|
8
Morgan Stanley
New York
| $2K | +$693 | +25 | +50% |
|
|
9
UBS Group
Zurich,
Switzerland
| $1K | -$2.25K | -81 | -62% |
|
10
Simplex Trading
Chicago,
Illinois
| $1K | +$1.33K | +48 | New |
|
|
VKH
11
Virtu KCG Holdings
New York
| – | -$24K | -681 | Closed |
|
|
12
Citadel Advisors
Miami,
Florida
| – | -$19K | -532 | Closed |
|
|
PCM
13
Prelude Capital Management
New York
| – | -$277 | -10 | -67% |
|
14
Bank of America
Charlotte,
North Carolina
| – | +$55 | +2 | New |
|
15
Creative Planning
Overland Park,
Kansas
| – | +$277 | +10 | New |
|
GENE Hedge Fund Activity: Q4 2016 in Review
15 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Genetic Technologies Ltd. (GENE) for Q4 2016, worth a combined $2.96M — up 224% from $915K a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new GENE positions and 3 closed out — a net gain of 4 holders — while 3 added to existing stakes and 2 trimmed.
The largest buyer was Sabby Management, opening a new position worth an estimated $1.48M. The largest seller was Virtu KCG Holdings, exiting entirely with an estimated $24K sold.
- 15 institutional investors held Genetic Technologies Ltd. (GENE) as of Q4 2016, up from 11 in Q3 2016.
- Funds reported $2.96M of Genetic Technologies Ltd. stock for Q4 2016, up 224% quarter-over-quarter.
- 7 funds opened new Genetic Technologies Ltd. positions in Q4 2016 and 3 closed out, a net change of +4 holders.
- The largest Genetic Technologies Ltd. buyer in Q4 2016 was Sabby Management, an estimated $1.48M added.
- The largest Genetic Technologies Ltd. seller in Q4 2016 was Virtu KCG Holdings, an estimated $24K sold.
Based on aggregated 13F filings for Q4 2016.